Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay

[1]  I. Sahin,et al.  Biomarkers in acute myocardial infarction: current perspectives , 2019, Vascular health and risk management.

[2]  M. Kurano,et al.  Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. , 2015, Clinical biochemistry.

[3]  C. Leithner,et al.  Serial Plasma Choline Measurements after Cardiac Arrest in Patients Undergoing Mild Therapeutic Hypothermia: A Prospective Observational Pilot Trial , 2013, PloS one.

[4]  N. Hayashi,et al.  Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients. , 2012, Clinical biochemistry.

[5]  H. Kirikoshi,et al.  Plasma free choline is a novel non‐invasive biomarker for early‐stage non‐alcoholic steatohepatitis: A multi‐center validation study , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  K. Shimada,et al.  Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[7]  Judith S. Hochman,et al.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[8]  E. Lonn,et al.  Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) Study , 2011, Circulation.

[9]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[10]  M. Möckel,et al.  Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability , 2010, Expert review of molecular diagnostics.

[11]  B. Khan,et al.  Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. , 2009, The American journal of cardiology.

[12]  R. Body,et al.  Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[13]  Martin Möckel,et al.  Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[14]  Y. Yatomi,et al.  Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity , 2008, Annals of clinical biochemistry.

[15]  A. Rockwood,et al.  Choline in whole blood and plasma: sample preparation and stability. , 2008, Clinical chemistry.

[16]  M. Nangaku,et al.  Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[17]  M. Möckel,et al.  Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[18]  H. Ikeda,et al.  Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. , 2007, Analytical biochemistry.

[19]  S. Zeisel,et al.  Sex and menopausal status influence human dietary requirements for the nutrient choline. , 2007, The American journal of clinical nutrition.

[20]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[21]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[22]  Kei Yamamoto,et al.  Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction* , 2006, Journal of Biological Chemistry.

[23]  Y. Kishi,et al.  Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[24]  M. Niculescu,et al.  Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. , 2006, The American journal of clinical nutrition.

[25]  C. Mummery,et al.  Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development , 2006, Molecular and Cellular Biology.

[26]  P. Ueland,et al.  Betaine: a key modulator of one-carbon metabolism and homocysteine status , 2005, Clinical chemistry and laboratory medicine.

[27]  M. Möckel,et al.  Whole-blood hypercholinemia and coronary instability and thrombosis. , 2005, Clinical chemistry.

[28]  M. Sugimachi,et al.  Myocardial interstitial choline and glutamate levels during acute myocardial ischaemia and local ouabain administration. , 2005, Acta physiologica Scandinavica.

[29]  Fred S Apple,et al.  Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. , 2005, Clinical chemistry.

[30]  K. Ellinger,et al.  Intestinal ischaemia during cardiac arrest and resuscitation: comparative analysis of extracellular metabolites by microdialysis. , 2003, Resuscitation.

[31]  S. Imamura,et al.  A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[32]  M. Möckel,et al.  Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. , 2003, The American journal of cardiology.

[33]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[34]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[35]  N. Dhalla,et al.  Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure. , 2002, Biochimica et biophysica acta.

[36]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[37]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[38]  M. Macey,et al.  Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.

[39]  K. Dilek,et al.  Changes of plasma free choline and choline-containing compounds' concentrations and choline loss during hemodialysis in ESRD patients. , 2002, Clinical biochemistry.

[40]  E. Alexander,et al.  Choline, an essential nutrient for humans , 1991, Nutrition.

[41]  M. Stanton,et al.  Homocysteine and cardiovascular disease , 2011 .

[42]  D. Jenden,et al.  Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.

[43]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[44]  J. Blusztajn,et al.  Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Schwenk,et al.  Choline uptake by isolated enterocytes of guinea pig. , 1984, The Journal of nutrition.

[46]  C. Mansbach,et al.  Determination of intracellular choline levels by an enzymatic assay. , 1983, Analytical biochemistry.

[47]  P. Kuchel,et al.  Measurement of choline concentration and transport in human erythrocytes by 1H NMR: comparison of normal blood and that from lithium-treated psychiatric patients. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[48]  K. Martin.  Concentrative Accumulation of Choline by Human Erythrocytes , 1968, The Journal of general physiology.